Complement Factor B Antikörper

Produktnummer ABIN2855659

Produktdetails anti-Complement Factor B Antikörper

Target: Complement Factor B (CFB)

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Complement Factor B Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Kreuzreaktivität: Human, Maus, Ratte

Produktmerkmale: Rabbit Polyclonal antibody to Factor B (complement factor B)
Factor B antibody [N2C2], Internal

Aufreinigung: Purified by antigen-affinity chromatography.

Immunogen: Recombinant protein encompassing a sequence within the center region of human Factor B. The exact sequence is proprietary.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB: 1:500-1:3000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.

Kommentare:

Validation: Orthogonal

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.87 mg/mL

Buffer: 0.1M Tris-Glycine ( pH 7), 20 % Glycerol, 0.01 % Thimerosal

Konservierungsmittel: Thimerosal (Merthiolate)

Vorsichtsmaßnahmen: This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.

Referenzen für anti-Complement Factor B Antikörper (ABIN2855659)

Zhu, Yao, Duan, Xu, Cheng, Gao, Li, Yang, Liu, Yuan: "Protein Expression Profile in Rat Silicosis Model Reveals Upregulation of PTPN2 and Its Inhibitory Effect on Epithelial-Mesenchymal Transition by Dephosphorylation of STAT3." in: International journal of molecular sciences, Vol. 21, Issue 4, (2020) (PubMed).

Details zu Complement Factor B

Target: Complement Factor B (CFB)

Andere Bezeichnung: complement factor B (CFB Produkte)

Synonyme: AHUS4 antikoerper, BF antikoerper, BFD antikoerper, CFAB antikoerper, FB antikoerper, FBI12 antikoerper, GBG antikoerper, H2-Bf antikoerper, PBF2 antikoerper, bf antikoerper, Bf-1 antikoerper, Brre-Bf antikoerper, zgc:114032 antikoerper, Bf antikoerper, Sp152 antikoerper, bfb-A antikoerper, Bf B antikoerper, LOC397725 antikoerper, bf/c2 antikoerper, CFB antikoerper, AI195813 antikoerper, AI255840 antikoerper, B antikoerper, C2 antikoerper, Fb antikoerper, Da1-24 antikoerper, complement factor B antikoerper, complement factor B S homeolog antikoerper, complement factor B L homeolog antikoerper, CFB antikoerper, cfb antikoerper, bf antikoerper, cfb.S antikoerper, cfb.L antikoerper, bf/c2 antikoerper, LOC100555981 antikoerper, Cfb antikoerper

Hintergrund: This gene encodes complement factor B, a component of the alternative pathway of complement activation. Factor B circulates in the blood as a single chain polypeptide. Upon activation of the alternative pathway, it is cleaved by complement factor D yielding the noncatalytic chain Ba and the catalytic subunit Bb. The active subunit Bb is a serine protease which associates with C3b to form the alternative pathway C3 convertase. Bb is involved in the proliferation of preactivated B lymphocytes, while Ba inhibits their proliferation. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. This cluster includes several genes involved in regulation of the immune reaction. Polymorphisms in this gene are associated with a reduced risk of age-related macular degeneration. The polyadenylation site of this gene is 421 bp from the 5' end of the gene for complement component 2.

Cellular Localization: Secreted

Molekulargewicht: 86 kDa

Gen-ID: 629

UniProt: P00751

Pathways: Komplementsystem, Proton Transport, Ribonucleoside Biosynthetic Process